Toyobo : Notice Regarding Recording of Extraordinary Losses (Impairment Losses) and Differences Between Forecasts for Fiscal Year Ended March 31, 2023 and Actual Results
May 11, 2023 at 12:14 am EDT
Share
May 11, 2023
To whom it may concern,
Name of company:
Toyobo Co., Ltd.
Name of representative:
Ikuo Takeuchi,
President & Representative Director
(Stock code: 3101, Prime Market of the Tokyo Stock Exchange)
Contact:
Sonoko Ishimaru,
Executive Officer, General Manager,
Corporate Communication Department
(TEL +81-6-6348-3044)
Notice Regarding Recording of Extraordinary Losses (Impairment Losses) and Differences Between Forecasts for Fiscal Year Ended March 31, 2023 and Actual Results
TOYOBO Co., Ltd. (hereinafter "the Company") hereby announces that the Company has recorded impairment losses on business assets, etc. for the fiscal year ended March 31, 2023. Accordingly, there are differences between the forecasts for the fiscal year ended March 31, 2023, which were announced on February 8, 2023, and the actual results. The details are described below.
1. Recording of extraordinary losses (impairment losses)
The Company's nonwoven materials business and engineering plastics business continued to post losses as they were impacted by the curtailment in automobile production and China's zero-COVID policy, and as product price revisions could not keep up with rising raw material and fuel prices. Based on the results of calculating future recoverability considering the current business environment, the recoverable amount of the business assets held by the said businesses fell below their carrying amount. Therefore, the Company reduced the carrying amount to the recoverable amount, and recorded the amount of the reduction as impairment losses of ¥8.2 billion.
In addition, based on the results of reviewing the recoverability of assets to be suspended and the business assets that continue to post losses among the non-current assets held by the Company and some subsidiaries, the Company recorded impairment losses of ¥1.6 billion.
Based on the above, the Company recorded impairment losses (consolidated) of ¥9.8 billion and impairment losses (non-consolidated) of ¥9.3 billion as extraordinary losses for the fiscal year ended March 31, 2023.
2. Differences between forecasts for fiscal year ended March 31, 2023 and actual results
Operating
Ordinary
Profit (loss)
Net profit
Net sales
attributable to
(loss)
profit
profit
owners of parent
per share
Millions of yen
Millions of yen
Millions of yen
Millions of yen
Yen
Previous Forecasts (A)
400,000
11,000
7,500
6,500
73.08
Revised Forecasts (B)
399,921
10,063
6,590
(655)
(7.37)
Change (B-A)
(79)
(937)
(910)
(7,155)
Percent Change (%)
(0.0)
(8.5)
(12.1)
-
(Reference)
Actual results for the fiscal year
375,720
28,430
23,092
12,865
144.75
ended March 31, 2022 (FY 3/2022)
3. Reasons for differences
The financial results for the fiscal year were impacted by rising raw material and fuel prices, and operating profit and ordinary profit were ¥0.9 billion lower than the previous forecasts. In addition, due to the reasons explained above in "1. Recording of extraordinary losses (impairment losses)," loss attributable to owners of parent for the fiscal year was ¥0.7 billion, which was ¥7.2 billion lower than the previous forecast.
The Company has not changed the forecast for the year-end dividend from ¥40 per share as announced on February 8, 2023.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Toyobo Co. Ltd. published this content on 11 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 May 2023 04:13:04 UTC.
Toyobo Co Ltd is a Japan-based company mainly engaged in the film and functional resin business, industrial material business, and textile and commerce business. It has five business segments. Film and Functional Resin segment manufactures, processes and sells packaging films, industrial films, industrial adhesives, engineering plastics and optical functional materials. Industrial Materials segment manufactures, processes and sells automotive fiber materials, super fibers, non-woven fabrics. Textile and Trading segment manufactures and sells functional clothing, apparel products, clothing textiles, and clothing fibers. Healthcare segment manufactures, processes and sells bio products, pharmaceuticals, medical membranes, medical devices, aqua membranes, and functional filters. It is also engaged in the assembly and sale of seawater desalination modules. The Real Estate segment sells, rents and manages movables. It also designs and constructs buildings and machinery and sells equipment.
Toyobo : Notice Regarding Recording of Extraordinary Losses (Impairment Losses) and Differences Between Forecasts for Fiscal Year Ended March 31, 2023 and Actual Results